Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Jun 12 · inside the Ichimoku cloud · RSI 64 · MACD below its signal
None of the 29 investors followed here reported a position in IONM in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a IONM trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for IONM.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | -74.4 | -99.0 | 0.0 | 0.0 | 47700.0 | -39.3 | 65.5 | 0.0 | 0.0 | 0.0 | 0.0 | -99.0 | −98.7% |
| 2024 | -4.0 | 41.7 | 41.2 | -0.4 | -13.5 | 0.2 | -92.6 | -64.3 | -35.0 | -43.6 | -1.2 | -46.1 | −99.1% |
| 2023 | 16.3 | -6.5 | -41.4 | -11.4 | -66.9 | -2.4 | -17.5 | -57.7 | -34.7 | 4.1 | 56.7 | -27.7 | −95.1% |
| 2022 | -18.4 | 24.9 | -1.8 | -20.7 | -59.1 | -16.6 | -30.1 | -12.2 | -28.6 | 7.8 | -42.0 | -35.0 | −95.2% |
| 2021 | 4.9 | 39.8 | -6.0 | -3.5 | -18.7 | 88.5 | -14.8 | -15.1 | -0.9 | -27.0 | 12.0 | -12.3 | +4.9% |
| 2020 | 7.1 | -19.0 | -38.3 | 5.9 | 25.0 | -1.2 | -21.3 | 28.6 | -0.2 | -25.4 | 28.4 | 19.8 | −18.9% |
| 2019 | 53.3 | -6.1 | -29.3 | -21.7 | 0.8 | -8.3 | 59.1 | 2.3 | -21.8 | 0.7 | -7.8 | -2.3 | −15.0% |
| 2018 | 9.8 | 7.4 | -55.7 | 47.1 | -4.9 | -12.0 | 15.4 | 0.5 | -15.2 | -8.6 | -3.2 | -0.4 | −44.2% |
| 2017 | 13.9 | 1.8 | -11.3 | 26.9 | -15.0 | +10.8% |
No analyst coverage for this instrument.
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. The company offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures that place the nervous system at risk. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing and collection services to support surgeons and medical facilities during invasive procedures. The company is based in Denver, Colorado.
No recent headlines.